About: Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 21 June 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 2007 (uk) article scientifique publié en 2007 (fr) im Juni 2007 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 21 June 2007 (en) artículu científicu espublizáu en xunu de 2007 (ast) գիտական հոդված հրատարակված 2007 թվականի հունիսի 21-ին (hy)
publication date	wds:Q80506436-1BDC2367-0297-4F53-BFFB-AD997DA08766
publication date	2007-06-21 00:00:00Z (xsd:dateTime)
exact match	wds:Q80506436-7BA7B64D-5892-462F-91BE-10D46D34B1EA
exact match	https://scigraph.springernature.com/pub.10.1038/sj.leu.2404819
cites work	wds:Q80506436-45E24F9E-6336-4953-8EAC-2A4AA134C5C8 wds:Q80506436-89DF5381-3918-4E8F-92DC-5777F16B8E22 wds:Q80506436-C0C0F9B9-9249-47B3-9E00-3F3E0E83F834 wds:Q80506436-C17637D4-44C5-4ED6-B3D6-51BF9D806421
cites work	Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma. Radioimmunotherapy for B-cell non-Hodgkin lymphoma Evaluation of the Coulter Counter model S-Plus IV
author name string	wds:Q80506436-24C039EA-26B3-44E9-8D9E-34A0E20D950C wds:Q80506436-3DAE731F-2824-47D5-A26C-3CE763B3CA40 wds:Q80506436-4A638F9E-D36C-4170-A79F-DE7513D4DDAE wds:Q80506436-528A0787-A4A1-4948-BF13-B272FDA1AC36 wds:Q80506436-891B6ABF-D28C-439C-9699-1053A6EFCBEC wds:Q80506436-9BEF7950-5896-4983-973A-17DC623206E8 wds:Q80506436-AE96DAE9-3401-44CA-B6A9-0C1EEE500630 wds:Q80506436-D09C4D5A-48AB-42F6-8CB7-0C8CE8C7FBE7 wds:Q80506436-DCA9ED36-DBEF-4C60-B3CF-E0AA21623C41 wds:Q80506436-EE6F9561-74F4-4A93-9F73-0C5C811A6323
author name string	T M Habermann D J Inwards I N Micallef L F Porrata P B Johnston S M Ansell T E Witzig S N Markovic K Ristow N Tuinistra
rdfs:label	Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas (en) Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas (nl)
skos:prefLabel	Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas (en) Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas (nl)
name	Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas (en) Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas (nl)
title	wds:Q80506436-A1628208-AA82-43E9-8B28-A3FDB047B3C4
title	Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas (en)
page(s)	wds:Q80506436-BB4A8212-919C-45DE-B652-AF3A6D55BB35
page(s)	2554-2556
instance of	wds:Q80506436-EA3C5F6E-E81E-43F5-AF13-ABE481CF7561
instance of	scholarly article
PubMed ID	wds:Q80506436-DE00B95D-F25B-4382-A36F-E71DAD2F672F
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17581607
PubMed ID	17581607
published in	wds:Q80506436-1BEB4999-D250-452A-AF67-30B8019D32B2
published in	Leukemia
issue	wds:Q80506436-A580F20A-6C54-4BE8-BBF2-DF94A37DE6F3
volume	wds:Q80506436-7F5F7799-15C2-40F2-B614-70CB8FA05EC2
issue	12
volume	21
DOI	wds:Q80506436-4E1235EA-2BE9-4313-848C-CE3CFE72CEC6
DOI	http://dx.doi.org/10.1038/SJ.LEU.2404819
DOI	10.1038/SJ.LEU.2404819
Dimensions Publication ID	wds:Q80506436-7E13FACC-E9C2-4CC3-B8DF-7C2F1E925859
Dimensions Publication ID	1019714361
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80506436
is cites work of	Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP. Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation. Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphoma. IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphoma SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma Prognostic significance of absolute lymphocyte count at diagnosis of diffuse large B-cell lymphoma: a meta-analysis Anaplastic lymphoma kinase-positive large cell lymphoma of the anterior skull base: Report of an unusual case and review of the literature Interleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy. Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independent data set
is cites work of	wds:Q37343931-DD84EAE1-7E57-411B-B061-2500D8576502 wds:Q35167257-6F3E6AED-F562-4279-81CF-0EC94AB0E95F wds:Q90703055-31AE96E8-A4D9-4639-9A70-35F4E9D3B8EB wds:Q35921894-851A2CE6-1509-4288-A018-19ABED783F10 wds:Q37972096-E131369A-A30F-4193-A626-7EB4915178BD wds:Q36806121-9AE40D36-CBD7-45D3-9D37-25BE3F73CCB7 wds:Q31116522-7CEA6C6F-34DB-4D52-904D-EC62CB0A13E2 wds:Q34388117-9E5C9B2E-3237-485E-A68A-E9C4FFC540CA wds:Q42591459-D4317C63-3D94-4728-BAA1-BA1CCE1248E1 wds:Q41008736-E68B9CA6-8F70-459C-83F9-98CD5266701C wds:Q57758877-9FA26E61-80FA-4E3D-9EB2-113E1ACDC647 wds:Q33802076-9A7E5DB3-F34F-461D-ABC3-0E55E97DBAAF wds:Q37100759-3BAB279A-CA6A-4119-82F0-1331BD3D2A5A wds:Q37685586-178F9168-593B-400C-85A3-463D5E6CB8CE

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software